Bayer Australia

Bayer is a global life sciences leader with a significant presence in Australia, focusing on healthcare and nutrition. The company's pharmaceutical division specializes in cardiology, oncology, ophthalmology, and women's health, delivering innovative treatments like Xarelto and Eylea. In addition to its prescription medicines, Bayer Australia manages a robust consumer health portfolio and a leading crop science business. The Australian arm plays a vital role in regional clinical development and provides access to cutting-edge therapies for local patients. Through strategic acquisitions like BlueRock Therapeutics and AskBio, Bayer is also expanding its capabilities into cell and gene therapies.